Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

ClinicalTrials.gov ID: NCT01138163

Public ClinicalTrials.gov record NCT01138163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this research study is to see whether adding bavituximab (an investigational drug) to the standard chemotherapy drug docetaxel, will improve the results of the treatment for non-small-cell lung cancer.

Study identification

NCT ID
NCT01138163
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Peregrine Pharmaceuticals
Industry
Enrollment
121 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
Sep 30, 2012
Completion
Apr 30, 2013
Last update posted
Apr 18, 2017

2010 – 2013

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Ironwood Cancer and Research Center Chandler Arizona 85224
South Bay Hematology Oncology Campbell California 95008
Medical Oncology Care Associates Orange California 92868
American Institute of Research Whittier California 90603
The Center for Hematology-Oncology/Boca Raton Community Hospital, Inc Boca Raton Florida 33486
Florida Cancer Specialists Fort Myers Florida 33916
Georgia Cancer Specialists, PC Atlanta Georgia 30341
Northwest Georgia Oncology Centers, PC Marietta Georgia 30060
Rush University Medical Center Chicago Illinois 60612
Cedar Valley Medical Specialists, PC Waterloo Iowa 50701
Jewish Hospital Louisville Kentucky 40202
Frederick Memorial Hospital Regional Cancer Therapy Center Frederick Maryland 21701
Nebraska Hematology Oncology, PC Lincoln Nebraska 68506
Hanover Medical Specialists, PA Wilmington North Carolina 28401
The Christ Hospital Cancer Center Research Cincinnati Ohio 45219
Oncology/ Hematology Care, Inc Cincinnati Ohio 45236
Dayton Clinical Oncology Program Dayton Ohio 45429
Pennsylvania State Hershey Cancer Institute Hershey Pennsylvania 17033
South Carolina Oncology Associates Columbia South Carolina 29210
Sarah Cannon Research Institute, LLC Nashville Tennessee 37203
Coastal Bend Cancer Center Corpus Christi Texas 78404
Mary Crowley Cancer Research Centers Dallas Texas 75201
University of Texas Southwestern Medical Center Dallas Texas 75390
University of Utah Hospitals and Clinics, Huntsman Cancer Institute Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01138163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2017 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01138163 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →